Yuli Guo

1.2k total citations
32 papers, 930 citations indexed

About

Yuli Guo is a scholar working on Public Health, Environmental and Occupational Health, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, Yuli Guo has authored 32 papers receiving a total of 930 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Public Health, Environmental and Occupational Health, 12 papers in Radiology, Nuclear Medicine and Imaging and 7 papers in Molecular Biology. Recurrent topics in Yuli Guo's work include Ocular Surface and Contact Lens (13 papers), Corneal Surgery and Treatments (10 papers) and Glaucoma and retinal disorders (5 papers). Yuli Guo is often cited by papers focused on Ocular Surface and Contact Lens (13 papers), Corneal Surgery and Treatments (10 papers) and Glaucoma and retinal disorders (5 papers). Yuli Guo collaborates with scholars based in China, United States and United Kingdom. Yuli Guo's co-authors include Jay D. Gralla, María‐Trinidad Gallegos, David J. Studholme, Martin Buck, Wei Li, Zuguo Liu, Jinghua Bu, Hui He, Peter S. Reinach and Yongxiong Chen and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Genes & Development.

In The Last Decade

Yuli Guo

27 papers receiving 915 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yuli Guo China 12 470 331 199 166 113 32 930
Qian Tan China 13 384 0.8× 267 0.8× 28 0.1× 198 1.2× 60 0.5× 26 858
Jinyu Wu China 26 1.1k 2.3× 441 1.3× 48 0.2× 88 0.5× 60 0.5× 73 1.9k
Stephanie Chu Singapore 12 689 1.5× 81 0.2× 42 0.2× 35 0.2× 94 0.8× 26 1.2k
W. L. Flowers United States 23 345 0.7× 366 1.1× 321 1.6× 52 0.3× 20 0.2× 53 1.5k
Anne‐Marie Brun‐Zinkernagel United States 10 408 0.9× 235 0.7× 34 0.2× 74 0.4× 74 0.7× 11 652
Yingying Li China 20 643 1.4× 92 0.3× 17 0.1× 79 0.5× 31 0.3× 81 1.1k
Hongyan Yang China 12 716 1.5× 396 1.2× 31 0.2× 77 0.5× 19 0.2× 25 1.1k
J. Marshall United Kingdom 20 870 1.9× 107 0.3× 28 0.1× 42 0.3× 87 0.8× 40 1.6k
Daisuke Muramatsu Japan 18 305 0.6× 99 0.3× 24 0.1× 85 0.5× 240 2.1× 50 992

Countries citing papers authored by Yuli Guo

Since Specialization
Citations

This map shows the geographic impact of Yuli Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuli Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuli Guo more than expected).

Fields of papers citing papers by Yuli Guo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuli Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuli Guo. The network helps show where Yuli Guo may publish in the future.

Co-authorship network of co-authors of Yuli Guo

This figure shows the co-authorship network connecting the top 25 collaborators of Yuli Guo. A scholar is included among the top collaborators of Yuli Guo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuli Guo. Yuli Guo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Guo, Yuli, et al.. (2025). Current Pharmaceutical Therapies for Meibomian Gland Dysfunction: From Basic Research to Clinical Practice. Clinical and Experimental Ophthalmology. 53(8). 1039–1055.
2.
Guo, Yuli, et al.. (2025). Postmarketing safety evaluation of pemetrexed using FAERS and JADER databases. Scientific Reports. 15(1). 18738–18738.
3.
Guo, Yuli, Rongrong Zhang, Minjie Zhang, et al.. (2025). Assessment of the clonal growth potential of meibomian gland stem/progenitor cells via clonal analysis. The Ocular Surface. 37. 1–10.
4.
Feng, Xiaofang, et al.. (2024). Exploring Stakeholder Perspectives on the Transitional Care Needs of Elderly Patients from Hospital to Home: A Phenomenological Study in Shanxi Province, China. Journal of Multidisciplinary Healthcare. Volume 17. 5457–5471. 1 indexed citations
5.
Bu, Jinghua, Yuli Guo, Yang Wu, et al.. (2024). Models for Meibomian gland dysfunction: In vivo and in vitro. The Ocular Surface. 32. 154–165. 5 indexed citations
6.
Guo, Yuli, et al.. (2024). Blood metabolites mediate effects of breakfast skipping on heart failure via Mendelian randomization analysis. Scientific Reports. 14(1). 18957–18957. 1 indexed citations
7.
Bu, Jinghua, Yang Wu, Minjie Zhang, et al.. (2023). Transitory alkali exposure on meibomian gland orifices induces meibomian gland dysfunction. The Ocular Surface. 29. 406–415. 5 indexed citations
8.
Guo, Yuli, Yaqiong Yang, Yuqian Wang, et al.. (2023). MAP4Ks inhibition promotes retinal neuron regeneration from Müller glia in adult mice. npj Regenerative Medicine. 8(1). 36–36. 11 indexed citations
9.
Guo, Yuli, et al.. (2023). Optimal vaccination strategies for COVID-19 in population migration between two regions scenario. Human Vaccines & Immunotherapeutics. 19(2). 2223108–2223108.
10.
Xu, Changsheng, Yuguang Chen, Yuqian Wang, et al.. (2023). Accurate detection and grading of pterygium through smartphone by a fusion training model. British Journal of Ophthalmology. 108(3). 336–342. 16 indexed citations
11.
Ji, Chunyan, Yuli Guo, Xin Luo, et al.. (2021). Inhibition of ceramide de novo synthesis ameliorates meibomian gland dysfunction induced by SCD1 deficiency. The Ocular Surface. 22. 230–241. 7 indexed citations
12.
Rui, Jian Raymond, et al.. (2021). What affected Chinese parents’ decisions about tuberculosis (TB) treatment: Implications based on a cross-sectional survey. PLoS ONE. 16(1). e0245691–e0245691. 3 indexed citations
13.
Li, Tingting, Bo Liu, W. F. Mader, et al.. (2020). TLR2/4 promotes PGE2 production to increase tissue damage in Escherichia coli-infected bovine endometrial explants via MyD88/p38 MAPK pathway. Theriogenology. 152. 129–138. 11 indexed citations
14.
Li, Sanming, Jing Zhou, Jinghua Bu, et al.. (2017). Ectodysplasin A protein promotes corneal epithelial cell proliferation. Journal of Biological Chemistry. 292(32). 13391–13401. 23 indexed citations
15.
Guo, Yuli, Wenjun Yu, Dongdong Sun, et al.. (2014). A novel protective mechanism for mitochondrial aldehyde dehydrogenase (ALDH2) in type i diabetes-induced cardiac dysfunction: Role of AMPK-regulated autophagy. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1852(2). 319–331. 90 indexed citations
16.
Guo, Yuli. (2013). Clinical observation of “Chuanshuting Granule” in treating bronchial asthma in 49 cases. Shanghai Journal of Traditional Chinese Medicine. 1 indexed citations
17.
Guo, Yuli. (2006). The clinical application of the low-dose CT examination. 1 indexed citations
18.
Guo, Yuli, et al.. (2000). Promoter opening by ς54 and ς70 RNA polymerases: ς factor-directed alterations in the mechanism and tightness of control. Genes & Development. 14(17). 2242–2255. 62 indexed citations
19.
Buck, Martin, María‐Trinidad Gallegos, David J. Studholme, Yuli Guo, & Jay D. Gralla. (2000). The Bacterial Enhancer-Dependent ς54(ςN) Transcription Factor. Journal of Bacteriology. 182(15). 4129–4136. 347 indexed citations
20.
Guo, Yuli & Jay D. Gralla. (1998). Promoter opening via a DNA fork junction binding activity. Proceedings of the National Academy of Sciences. 95(20). 11655–11660. 85 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Qian Tan Breakdown of academic impact, for papers by Jinyu Wu Breakdown of academic impact, for papers by Stephanie Chu Breakdown of academic impact, for papers by W. L. Flowers Breakdown of academic impact, for papers by Anne‐Marie Brun‐Zinkernagel Breakdown of academic impact, for papers by Yingying Li Breakdown of academic impact, for papers by Hongyan Yang Breakdown of academic impact, for papers by J. Marshall Breakdown of academic impact, for papers by Daisuke Muramatsu
Rankless by CCL
2026